Business · 05/08/2024Updated: 10/17/2026 · 1 min read
FDA Renews Drug Safety and Risk Management Advisory Committee for 2 Years
Summary
The Food and Drug Administration (FDA) has renewed the Drug Safety and Risk Management Advisory Committee for an additional 2 years, with the new charter set to expire on May 31, 2026.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →